Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer. - Hsu, Hung‐Chih; Liu, Yu‐Chun; Wang, Chuang‐Wei; Chou, Wen-Chi; Hsu, Yu-Jen; Chiang, Jy-Ming; Lin, Yung-Chang; Yang, Tsai-Sheng (Cancer Medicine, 2019)